Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0022116 (ischemia)
 91,303 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Chest pain is a common complaint among hypertensive patients. Hypertension and coronary heart disease each may present with symptoms and signs that are clinically indistinguishable. Noninvasive testing by routine exercise stress testing and stress radionuclide angiography are not reliably predictive of ischemia resulting from obstructive epicardial coronary artery disease and should be abandoned for that diagnostic purpose. Noninvasive thallium-201 myocardial perfusion imaging for this purpose may prove to be a valuable tool, avoiding the risk and expense of coronary arteriography. However, carefully performed prospective studies are not available. Because of the high prevalence of both diseases, a high priority must be given to obtaining these data and evaluating other noninvasive methods (especially positron emission tomography) if they appear promising.
 ...
PMID:How can we diagnose coronary heart disease in hypertensive patients? 295 21

Coronary heart disease has many different clinical courses: it can cause rhythm-disturbances, sudden death, pump-failure, no pain at all (silent ischemia) or typical angina. Heart-pain can occur "on demand" after physical or mental stress with a duration of 3 to 5 minutes with typical location and good response to nitrates. It also can cause atypical forms of angina such as angina on rest, mostly due to coronary spasms. Angina can stable over months and years but can suddenly increase in severity and duration. This form is called unstable angina, which has to be recognized as soon as possible since acute myocardial infarctions evolve rather frequently. Infarction is an irreversible myocardial damage but before it develops many measures can be taken to preserve the jeopardized myocardium. The recognition and differentiation of angina pectoris is therefore of utmost importance.
 ...
PMID:[Angina pectoris]. 305 92

Twenty-five men aged 53-70 years, with stable intermittent claudication and similar symptoms and walking distance, were investigated with myocardial scintigraphy, duplex ultrasonography of carotid arteries and femoral angiography. Each patient was scored according to the degree of stenosis in the popliteal trifurcation and the aortoiliac and carotid arteries. Eighteen of the 25 men had coronary heart disease, which was clinically evident in nine cases and scintigraphically demonstrated in 17/24. Ischemia or infarction without clinical manifestation was located in the atrio-ventricular septal region in all nine cases. Eight of the 25 patients were shown to have carotid lesions. Significant correlation was found between lesions in the trifurcation and in the carotid arteries, but not between aortoiliac and carotid lesions. Trifurcational disease was a somewhat weaker marker for coronary heart disease. The high prevalence of coronary heart disease is noteworthy, especially the septal pathology, and further studies on the clinical significance of the findings appear to be urgently required.
 ...
PMID:High prevalence of coronary heart disease in patients with intermittent claudication. A preliminary report. 305 77

Numerous investigators have demonstrated that responses to exercise testing enable prediction of the severity of underlying coronary disease and the patient's prognosis. However, exercise testing cannot predict angiographic findings or a poor prognosis with absolute certainty. Because survival can only be improved in specific clinical subsets of patients, it is important to carefully select for catheterization those in whom intervention can improve both quality and quantity of life. To deliver cost-effective health care, an effort has been made to use decision analysis to select those who should undergo cardiac catheterization. Decision analysis depends on reliable information regarding the predictive accuracy of the exercise test. Thus, this review is timely. Recent studies investigating the prognostic value of the exercise test are reviewed in this monograph. Patients include those recovering from a recent myocardial infarction (MI), those with stable coronary heart disease (including studies that have considered coronary angiographic findings, cardiac end points, and/or improved survival with coronary artery bypass surgery), and apparently healthy individuals. From this review, we conclude that silent ischemia induced by exercise testing in apparently healthy men is not as predictive of a poor outcome as once thought. Also, the use of the exercise test for screening is even more misleading than previously appreciated because of the higher rate of false positive results. Review of the 24 available studies of exercise testing in post-MI patients demonstrates that clinical judgment can be used to identify the high-risk patients, and that ST-segment shifts are not as predictive of high risk as an abnormal systolic blood pressure response or a poor exercise capacity. In patients with stable coronary heart disease, studies considering angiographic findings, cardiac events, and the differential outcome of coronary artery bypass surgery as compared with medical therapy have shown the exercise test to have prognostic power. From this perspective, it is obvious that there is much information supporting the use of exercise testing as the first noninvasive step after the history, physical examination, and resting electrocardiogram in the prognostic evaluation of patients with coronary artery disease. It accomplishes both purposes of prognostic testing: to provide information regarding the patient's status, and to help make recommendations for optimal management. The exercise test results help us make reasonable decisions for selection of patients who should undergo coronary angiography-including quality-of-life issues.(ABSTRACT TRUNCATED AT 400 WORDS)
 ...
PMID:The prognostic value of the exercise test. 305 76

The treatment of 15 patients with coronary heart disease and exertion-related angina pectoris with isosorbide dinitrate (ISDN) tablets in 4 doses (6 X 5 mg, 6 X 20 mg, 6 X 40 mg, 6 X 80 mg) in a randomized sequence for 1 week each resulted in a dose-related improvement of ischemia (ST-segment depression during stress testing) as compared to placebo: 5 mg (30 mg/day): 24% (p less than 0.05); 20 mg (120 mg/day): 40% (p less than 0.05); 40 mg (240 mg/day): 60% (p less than 0.01); 80 mg (480 mg/day): 74% (p less than 0.01). Continuation of treatment for another 4 weeks with 480 mg/day led to a slight decrease in antianginal activity, with a 55% improvement of ST-depression. The frequency of angina pectoris was also lowered in a dose-related manner. For nitroglycerin in oral sustained release form (matrix system) a dose-related antianginal efficacy could be demonstrated in 12 patients enrolled in a double-blind cross-over trial: 2.6 mg (single dose): 23% (n.s.); 6.5 mg: 38% (p less than 0.01); 10 mg: 55% (p less than 0.001); 20 mg: 74% (p less than 0.0001). The duration of action of 20 mg was 4 hours. Transdermal nitroglycerin also proved to be effective in a dose related fashion. In 12 patients undergoing 1-week treatment periods with 5 cm2, 10 cm2 and 20 cm2-patches ST-depression was favourably influenced by 15% (n.s.), 22% (p less than 0.05) and 46% (p less than 0.001) 3 hours after administration. No antiischemic efficacy was demonstrable 24 hours after medication.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:[Dose-response relationship of nitrate therapy of angina pectoris]. 309 86

163 patients underwent surgery for acute ischemia of the lower extremity between 1982 and 1986. Thrombosis was present in 50 cases and embolism in 113. Half of the patients with thrombosis showed signs of chronic occlusive disease of the arteries (intermittent claudication); in the latter group 2/3 of the patients had atrial fibrillation and 1/4 coronary heart disease. For embolism Fogarty-catheter clot extraction was performed, mainly under local anesthesia. This procedure is easy to perform even under emergency conditions (mortality 10%, amputation rate 8%). In contrast, the surgical procedure in thrombotic occlusion was more demanding (mortality 4%, amputation rate 16%) and in the case of severe ischemia had to be carried out on an emergency basis. In case of less severe ischemia the treatment consisted in initial heparinization and elective revascularization when the patient was stabilized. A new therapeutic approach involving local catheter thrombolysis, catheter clot aspiration and balloon dilatation is presented. The combined catheter intervention produces good results in 70% of patients, particularly those with femoral thrombosis.
 ...
PMID:[Clinical aspects and treatment of acute arterial occlusion]. 314 37

Regional myocardial perfusion and glucose metabolism were assessed in six normal volunteers and 29 patients with coronary heart disease and stable or unstable angina using rubidium-82 (Rb-82) and F-18 fluoro 2-deoxy-D-glucose (FDG) with positron emission tomography. All normals and patients were studied following overnight fasting, at rest, with no angina or electrocardiographic signs of acute myocardial ischemia or necrosis. Rb-82 myocardial cross-sectional images were obtained employing the continuous infusion technique, while dynamic FDG imaging was employed after intravenous tracer bolus injection. Regional Rb-82 and FDG myocardial concentrations were then calculated by drawing regions of interest over the interventricular septum, anterior and lateral wall of the left ventricle. The mean Rb-82 uptake for each left ventricular region analyzed was found to be similar between both groups of patients and normal volunteers. The mean myocardial glucose utilization was found to be similar in normal volunteers and patients with stable angina (0.023 +/- 0.032 vs. 0.012 +/- 0.008 microns ml/min p less than 0.42). However, myocardial glucose utilization was found to be significantly higher in patients with unstable angina compared with both normals and patients with stable angina (0.048 +/- 0.047 microM/ml/min p less than 0.001 for both comparisons). Thus, in patients with severe coronary artery disease and unstable angina, myocardial glucose utilization was enhanced in spite of the absence of clinical, electrocardiographic, or detectable perfusion evidence of acute ischemia.
 ...
PMID:Abnormalities in myocardial metabolism in patients with unstable angina as assessed by positron emission tomography. 315 93

The accuracy of radionuclide techniques for detection of exercise-induced myocardial ischemia was analyzed with TL-201 single-photon emission computer tomography (SPECT) and gated blood pool ventriculography in 31 patients. Reversible and persistent perfusion defects in the biphasic SPECT studies, parametric phase and amplitude images and global indices of left ventricular function were evaluated and compared to the results of exercise cineventriculography. Out of 25 patients with coronary heart disease, 20 had exercise-induced ischemia and 17 patients had a prior myocardial infarction. SPECT detected ischemia with a sensitivity of 85% and a specificity of 100%, gated blood pool ventriculography had a sensitivity of 60% and a specificity of 91%. Both scintigraphic methods were comparable in the detection of myocardial infarcts (SPECT/gated blood pool ventriculography: sensitivity 88%/82%; specificity 100%/93%; positive predictive value 100%/93%). A difference in detection of ischemia between both methods was found in patients with myocardial infarct and additional ischemia: all patients with additional ischemia were detected by SPECT, whereas gated blood pool ventriculography failed to identify the additional ischemia in 1/4 of these patients (p less than 0.05).
 ...
PMID:[Detection of ischemia with thallium-201 single photon emission computerized tomography (SPECT) and radionuclide ventriculography in comparison with stress cineventriculography]. 325 52

The development of myocardial scintigraphy (MS) reflects the clinical success of a representative procedure in nuclear medicine. Radiopharmaceuticals for visualizing vital and damaged myocardium and techniques (planar-qualitative, planar-quantitative, SPECT-qualitative-quantitative with comparative sensitivities) are briefly reviewed with the main focus on their clinical application in coronary (CHD) and noncoronary heart disease, where recent literature from the United States and Europe is considered. The limited value of MS for screening of CHD is outlined and its present and future role in detecting asymptomatic (silent) ischemia/infarction and symptomatic patients at professional risk is stressed. The present state of MS in coronary heart disease is discussed for single and multivessel disease, previous infarction, and risk stratification (myocardial washout, pulmonary uptake, ischemic dilation, absent heart sign), reflecting the importance of the procedure in exercise-induced ischemia as well as in ischemia at rest for prognostication of the natural and therapeutic course, i.e., therapy control (angioplasty, bypass, lysis, cardiac drugs). More marginal but upcoming clinical indications are mentioned, such as progressive systemic sclerosis, cardiac transplantation, pediatric cardiology, and problems of nephrology/urology. The "normal" values and the impact of digital radiology and of contrast cardiography are touched upon. Preliminary cases with 111In-antimyosin and 99mTc-Isonitriles are presented including correlative results between global ejection fraction determination according to gated 99mTc-isonitrile and conventional 99mTc-erythrocyte ventriculogram (r = 0.75; n = 10).
 ...
PMID:Myocardial scintigraphy--25 years after start. 328 85

Atherogenic traits, living habits, signs of preclinical disease, and susceptibility all contribute to cardiovascular disease. High low-density lipoprotein is positively related to coronary heart disease, and high high-density lipoprotein is inversely related. Systolic or diastolic hypertension at any age in either sex contributes powerfully. The impact of diabetes is greater for women and varies with the number of accompanying risk factors. High-normal fibrinogen values further escalate risk of these atherogenic factors. An atherogenic life-style is typified by a diet excessive in fat, calories, and salt; sedentary habits; unrestrained weight gain; and cigarette smoking. Moderate alcohol use may be beneficial. Use of oral contraceptives beyond age 35 years and in conjunction with cigarette smoking predisposes one to thromboembolism. Type A behavior carries an increased risk, and men married to more highly educated women and to women in white-collar jobs are more vulnerable. Signs of preclinical ischemia include silent myocardial infarction, left ventricular hypertrophy on ECG, blocked intraventricular conduction, and repolarization abnormalities. Measures of innate susceptibility include a family history of early cardiovascular disease. Quantitative combination of risk factors provides optimal prediction, including persons with multiple marginal abnormalities. Preventive management should also be multifactorial and requires a commitment to behavior modification and alteration in life-style.
 ...
PMID:New perspectives on cardiovascular risk factors. 330 Feb 33


<< Previous 1 2 3 4 5 6 7 8 9 10